RMTG (Regenerative Medical Technology Group) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RMTG Regenerative Medical Technology Group Inc RMTG
28 GF Score
Price $0.11
GF Value $0.06
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Regenerative Medical Technology Group Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

RMTG
28GF Score
Regenerative Medical Technology Group Inc RMTG
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Regenerative Medical Technology Group (RMTG) Overvalued in 2026?

Based on GuruFocus' analysis, Regenerative Medical Technology Group stock appears to be overvalued. The current stock price of $0.11 is trading 83.5% above its estimated GF Value™ of $0.06. GuruFocus considers Regenerative Medical Technology Group to be Significantly Overvalued.

Key valuation signals for RMTG:

  • Dividends Received:
  • GF Value™: $0.06 vs. price of $0.11 (83.5% above fair value)
  • GF Score™: 28/100 with 6 warning signs

No single metric tells the full story. See the RMTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.
28GF Score

Get the complete analysis for RMTG

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.06
GF Value